---
title: "TREACE MEDICAL CONCEPTS, INC. (TMCI) stock and investor profile"
url: "https://aibio.space/companies/treace-medical-concepts/"
publisher: "aibio.space (Biotech Investor Relations News)"
summary: "TREACE MEDICAL CONCEPTS, INC. (NASDAQ: TMCI), United States. Listing facts, related biotech companies and news on aibio.space."
---

TMCI TREACE MEDICAL CONCEPTS, INC. NASDAQ · United States

# TREACE MEDICAL CONCEPTS, INC. (TMCI) news

TREACE MEDICAL CONCEPTS, INC. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker TMCI, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

## Latest TREACE MEDICAL CONCEPTS, INC. news

We have not published a story on TREACE MEDICAL CONCEPTS, INC. yet. When there is news, it will appear here.

## TREACE MEDICAL CONCEPTS, INC. at a glance

- **Ticker**: TMCI

- **Listing**: NASDAQ

- **Country**: United States

- **Cash, Jun 30, 2026**: $45.6 million

### Related companies

- [VOLITIONRX LTD](https://aibio.space/companies/volitionrx/) NYSE: VNRX
- [TRINITY BIOTECH](https://aibio.space/companies/trinity-biotech/) NASDAQ: TRIB
- [CHARLES RIVER LABORATORIES INTERNATIONAL, INC.](https://aibio.space/companies/charles-river-laboratories-international/) NYSE: CRL
- [National Vision Holdings](https://aibio.space/companies/national-vision/) NASDAQ: EYE
- [Bioventus](https://aibio.space/companies/bioventus/) NASDAQ: BVS
- [LFTD PARTNERS INC.](https://aibio.space/companies/lftd-partners/) OTC: LIFD
- [PRECISION OPTICS CORPORATION, INC.](https://aibio.space/companies/precision-optics/) NASDAQ: POCI
- [BIOFORCE NANOSCIENCES HOLDINGS, INC.](https://aibio.space/companies/bioforce-nanosciences/) OTC: BFNH

### Also on NASDAQ

- [Allarity Therapeutics](https://aibio.space/companies/allarity-therapeutics/) ALLR
- [Krystal Biotech](https://aibio.space/companies/krystal-biotech/) KRYS
- [Revolution Medicines](https://aibio.space/companies/revolution-medicines/) RVMD
- [MindWalk Holdings](https://aibio.space/companies/mindwalk/) HYFT
- [Aurinia Pharmaceuticals](https://aibio.space/companies/aurinia-pharmaceuticals/) AUPH
- [Lifeward](https://aibio.space/companies/lifeward/) LFWD

## TREACE MEDICAL CONCEPTS, INC. annual financials

| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | [$212.7 million](https://www.sec.gov/Archives/edgar/data/1630627/000119312526079167/) | [$209.4 million](https://www.sec.gov/Archives/edgar/data/1630627/000119312526079167/) |
| Research and development | [$20.3 million](https://www.sec.gov/Archives/edgar/data/1630627/000119312526079167/) | [$20.6 million](https://www.sec.gov/Archives/edgar/data/1630627/000119312526079167/) |
| Net income (loss) | [-$59.0 million](https://www.sec.gov/Archives/edgar/data/1630627/000119312526079167/) | [-$55.7 million](https://www.sec.gov/Archives/edgar/data/1630627/000119312526079167/) |
| Cash from operations | [-$16.0 million](https://www.sec.gov/Archives/edgar/data/1630627/000119312526079167/) | [-$37.2 million](https://www.sec.gov/Archives/edgar/data/1630627/000119312526079167/) |
| Cash and equivalents | [$10.7 million](https://www.sec.gov/Archives/edgar/data/1630627/000163062726000018/) | [$11.3 million](https://www.sec.gov/Archives/edgar/data/1630627/000119312526079167/) |
| Short-term investments | [$37.7 million](https://www.sec.gov/Archives/edgar/data/1630627/000163062726000018/) | [$64.3 million](https://www.sec.gov/Archives/edgar/data/1630627/000119312526079167/) |

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $12.6 million, plus short-term investments of $33.0 million, $45.6 million in all.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

## Questions about TREACE MEDICAL CONCEPTS, INC.

What is the ticker symbol of TREACE MEDICAL CONCEPTS, INC.?

TREACE MEDICAL CONCEPTS, INC. trades under the ticker TMCI on NASDAQ.

Where is TREACE MEDICAL CONCEPTS, INC. listed?

TREACE MEDICAL CONCEPTS, INC. is listed on NASDAQ.

Which country or territory is TREACE MEDICAL CONCEPTS, INC. listed under?

Our directory records TREACE MEDICAL CONCEPTS, INC. under United States.

Does aibio.space cover TREACE MEDICAL CONCEPTS, INC.?

aibio.space lists TREACE MEDICAL CONCEPTS, INC. among 2,820 public biotech companies and publishes its news here as stories appear.

What was TREACE MEDICAL CONCEPTS, INC.'s revenue last year?

$212.7 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.

Is TREACE MEDICAL CONCEPTS, INC. profitable?

TREACE MEDICAL CONCEPTS, INC. reported a net loss of $59.0 million for the fiscal year ended Dec 31, 2025, and used $16.0 million of cash in operations, per its annual report to the SEC.

How much does TREACE MEDICAL CONCEPTS, INC. spend on research and development?

$20.3 million in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does TREACE MEDICAL CONCEPTS, INC. have?

$45.6 million in cash and short-term investments at Jun 30, 2026, per its 10-Q.

## Investor discussion: TREACE MEDICAL CONCEPTS, INC.

Members talk about TREACE MEDICAL CONCEPTS, INC. (TMCI). Reader posts, not aibio.space reporting, and not investment advice.

Rules

1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
2. **Say whether you hold the stock.** Every post states long, short or no position.
3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you.
4. **No buy or sell calls and no price targets.**
5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them.
6. **No personal details and no spam.** No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion).

## Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:TMCI on TradingView](https://www.tradingview.com/symbols/NASDAQ-TMCI/).

## Listing details

TREACE MEDICAL CONCEPTS, INC. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker TMCI, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

- **Company**: TREACE MEDICAL CONCEPTS, INC.

- **Ticker**: TMCI

- **Listing**: NASDAQ

- **Country or territory**: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/).

Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/).

Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update)

---
Source page: https://aibio.space/companies/treace-medical-concepts/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "TREACE MEDICAL CONCEPTS, INC. (TMCI) stock and investor profile", 2026-10-31, https://aibio.space/companies/treace-medical-concepts/
